BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MN-08 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MN-08\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05660863-570@assetmemo.bio
DTSTAMP:20261121T005408Z
DTSTART;VALUE=DATE:20280330
DTEND;VALUE=DATE:20280331
SUMMARY:MN-08: Phase 1 readout est. (NCT05660863)
DESCRIPTION:MN-08\, phase 1.\nStudy: A Multiple Dose Study to Investigate S
 afety\, Tolerability and Pharmacokinetics of MN-08 Tablets\nEstimated prim
 ary completion: 30 March 2028. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/mn-08#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT05660863
URL:https://assetmemo.bio/drug/mn-08#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
